No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Chemicals - Specialty
Avantium N.V., an Amsterdam-based chemical technology enterprise, specializes in the development and commercialization of sustainable chemistry innovations. Its operations are structured across three distinct segments: Avantium Catalysis, Avantium Renewable Chemistries, and Avantium Renewable Polymers. A core focus is on furandicarboxylic acid (FDCA), which serves as a crucial precursor for polyethylene furanoate (PEF) – a bio-based, recyclable plastic ideal for packaging applications. The company also supplies advanced catalyst testing systems, including its proprietary Flowrence system, designed for evaluating catalysts and adsorbents, alongside offering R&D support and refinery catalyst assessment services. Avantium is pioneering technologies such as "ray technology" for producing mono-ethylene glycol from industrial sugars and "dawn technology" for transforming non-food plant feedstocks into industrial sugars and lignin. These initiatives, along with its use of plantMEG for polyester manufacturing, underscore its commitment to renewable resources. Founded in 2000, Avantium N.V. continues to drive progress in green chemistry.
www.avantium.comNo one on the platform currently holds AVTX.AS.
No tracked institution reports a position in AVTX.AS as of their last filing.
No one on the platform has traded AVTX.AS yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Analyst estimates unavailable for this ticker.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $31M | +73.8% | $-1.93 | $-2.40–$-1.59 | — | 4 |
| 2027 | $59M | +91.8% | $-0.84 | $-1.22–$-0.31 | — | 3 |
| 2028 | $82M | +39.1% | $-0.50 | $-0.61–$-0.41 | — | 3 |
| 2029 | $110M | +34.6% | $-0.96 | $-1.18–$-0.79 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
| Symbol | Price | Today | Mkt cap | P/E |
|---|---|---|---|---|
| AVTX.ASAvantium N.V. | $4.94 | +2.07% | $43M | — |
| ALFEN.ASAlfen N.V. | $11.18 | -0.36% | $243M | — |
| AMG.ASAMG Critical Materials N.V. | $28.90 | -0.89% | $1.0B | — |
| BESI.ASBE Semiconductor Industries N.V. | $176.35 | +0.23% | $14.0B | — |
| CRBN.ASCorbion N.V. | $22.48 | -0.79% | $1.3B | — |
| PHARM.ASPharming Group N.V. | $0.91 | -2.72% | $644M |
Source: Financial Modeling Prep · peers by sector/industry
| — |